Jules Müsing
Direktor/Vorstandsmitglied bei Delphi Digital, Inc.
Aktive Positionen von Jules Müsing
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Delphi Digital, Inc.
 Delphi Digital, Inc. Internet Software/ServicesTechnology Services Delphi Digital, Inc. engages in the provision of internet services. It offers an online personal management tools to individuals, families, and organizations. The company is headquartered in Rancho Mirage, CA. | Direktor/Vorstandsmitglied | 01.03.2012 | - |
Karriereverlauf von Jules Müsing
Ehemalige bekannte Positionen von Jules Müsing
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| THERAPEUTICSMD, INC. | Direktor/Vorstandsmitglied | 16.05.2013 | 30.12.2022 |
| Independent Dir/Board Member | 16.05.2013 | 30.12.2022 | |
| IBIO, INC. | Direktor/Vorstandsmitglied | 01.01.2012 | 01.01.2014 |
| Independent Dir/Board Member | 01.01.2012 | 01.01.2014 | |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01.01.2003 | 01.09.2010 |
Biotech Ortho SAS
 Biotech Ortho SAS Medical DistributorsDistribution Services Part of Stryker Corp., Biotech Ortho SAS is a French company that wholesales pharmaceutical products. The company is based in Salon-de-Provence, France. | Vorstandsvorsitzender | 01.10.1999 | 01.01.2003 |
| Ortho Biotech, Inc. | Direktor/Vorstandsmitglied | 01.01.1993 | 01.10.1999 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Präsident | 01.04.1990 | 01.01.1993 |
| Janssen Farmaceutica Portugal Lda. | Vorstandsvorsitzender | 01.07.1987 | 01.03.1990 |
| Pitman-Moore, Inc. | Präsident | 01.01.1985 | 01.06.1987 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Jules Müsing
| University of Antwerp | Undergraduate Degree |
| Vrije Universiteit Brussel | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
| Belgien | 3 |
| Frankreich | 2 |
Operativ
| Director/Board Member | 5 |
| Independent Dir/Board Member | 2 |
| President | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| IBIO, INC. | Health Technology |
| THERAPEUTICSMD, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Delphi Digital, Inc.
Delphi Digital, Inc. Internet Software/ServicesTechnology Services Delphi Digital, Inc. engages in the provision of internet services. It offers an online personal management tools to individuals, families, and organizations. The company is headquartered in Rancho Mirage, CA. | Technology Services |
| Pitman-Moore, Inc. | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
| Ortho Biotech, Inc. | |
Biotech Ortho SAS
Biotech Ortho SAS Medical DistributorsDistribution Services Part of Stryker Corp., Biotech Ortho SAS is a French company that wholesales pharmaceutical products. The company is based in Salon-de-Provence, France. | Distribution Services |
| Janssen Farmaceutica Portugal Lda. | |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Health Technology |
- Börse
- Insiders
- Jules Müsing
- Erfahrung
